Roger Joseph Hajjar

Director at Longeveron.

Raised on Longeveron filings

$15.9M

of $33.5M offered across 1 Form D filing

Form D filings: 1
Teammates: 9
Last filing: Mar 25, 2026

Company

Biotech · Miami, FL

Bone marrow cell therapy for heart defects and frailty

Bone marrow cell therapy for heart defects and frailty

Investors: 7
Still open: $17.6M

Investors: 7
Sector: Biotech
HQ: Miami, FL

Longeveron filings

Longeveron Form D filings
Filed	Security	Sold of offered	Filing
Mar 25, 2026	Equity	$15.9M/ $33.5M	Form D

EquityFiled Mar 25, 2026Form D
$15.9M/ $33.5M

Works with

Also named on Longeveron filings

Lisa A. LocklearChief Financial Officer, Form D signerForm D signer George Paletta, Jr.Director Joshua M. HareExecutive Officer, Director Stephen H. WillardExecutive Officer Devin BlassExecutive Officer Nataliya AgafonovaExecutive Officer Paul LehrExecutive Officer Rock SofferDirector Ursula UngaroDirector